Ms Brenda Shanahan, Chair
Ms Shanahan has a longstanding background in Australian and overseas economies and share markets and is a Fellow of the Institute of Directors. She is currently Chair of St. Vincent's Medical Research Institute in Melbourne, a non executive Director of Challenger Ltd., Clinuvel Pharmaceuticals Ltd., Bell Financial Group Ltd and DMP Asset Management Ltd, and a director of the Kimberley Foundation of Australia. She has recently been appointed as a member of Swinburne University's Inaugural Industry Research Advisory Committee. Brenda is also a former member of the Australian Stock Exchange and Chair of St. Vincent's Health Melbourne Ltd and director of St. Vincent's Health Australia Ltd.
Mr Tony D'Aloisio AM
Tony has over 30 years experience as a senior executive in government, corporate and legal roles. He is currently Chairman of IRESS Ltd. He was appointed as a Commissioner for the Australian Securities and Investment Commission (ASIC) in late 2006 and then as Chairman in 2007 for a four-year term. He was Chairman of the (International) Joint Forum of the Basel Committee on Banking Supervision from 2009 to 2011. Prior to ASIC, he was Managing Director and Chief Executive Officer at the Australian Securities Exchange (ASX) from 2004 to 2006. Tony was Chief Executive Partner at Mallesons Stephen Jaques between 1992 and 2004, having first joined the firm in 1977. Tony has a depth of experience in executive and non-executive roles.
Mr JT Macfarlane
Mr Macfarlane is non-Executive Director of both public and private companies in Australia and New Zealand. He retired from his executive role as Chairman and CEO of Deutsche Bank Group, Australia & New Zealand in 2014. Prior to returning to Australia in 2007, he spent seven years as President and CEO of Deutsche Bank, Japan. An economist by training, Mr Macfarlane held senior positions with Bankers Trust in Sydney, New York and New Zealand until its acquisition by Deutsche Bank in 1999. At Deutsche Bank he served on the Global Markets Executive Committee, the Global Banking Executive Committee and the Global Regional Management Committee of Deutsche Bank; as well as Co-Chair of the Asia Pacific Deutsche Bank Executive Management Committee.
Adj Professor Susan O’Neill
Susan O'Neill is the CEO of St Vincent’s Hospital Melbourne. Sue took the helm at St Vincent’s in 2016, after nearly two years in charge of Albury Wodonga Health, and five years as Executive Director of Nursing of Cabrini Health. Sue has a passion for organisational excellence and has spent many years applying lean thinking principles to health care. Her specific focus has been in the areas of strategy development and deployment, integrated operational planning, patient flow & practice redesign, leadership, coaching and talent development. Sue is currently studying an executive MBA, has qualifications in cancer nursing and holds a Master of Nursing Science, as well as being a fellow of the University of Pennsylvania Wharton Business School.
Ms Patricia O’Rourke
Patricia O’Rourke is the CEO of St Vincent’s Health Australia’s Public Hospitals Division. The Public Hospital Division is made up of two major tertiary and quaternary health networks in Victoria and NSW, worth $1.2B and with over 11,000 employees. Prior to this, Patricia was the CEO of St Vincent’s Hospital Melbourne. Patricia has more than 20 years’ experience in the health care industry, including nursing and senior management roles. Patricia currently serves as a Director on the Boards of St Vincent's Institute of Medical Research, VESKI, the Garvan Institute of Medical Research and the Thomas Kelly Youth Foundation. She is also appointed to other health care advisory boards in both NSW and Victoria. Patricia is a graduate of the Australian Institute of Company Directors and a member of the Harvard Business Club of Australia.
Professor Tom Kay
Professor Tom Kay is the Executive Director of ACMD, and the Director of St Vincent's Institute of Medical Research (SVI), a position he has held for more than 13 years. He is also an Honorary Endocrinologist, St Vincent’s Hospital Melbourne and Honorary Professorial Fellow, University of Melbourne, Department of Medicine at St Vincent’s Hospital. He is alo the Director of the Tom Mandel Islet Transplant Program at St Vincent’s, which carried out Victoria’s first successful islet transplant. Tom leads Australia’s largest type 1 diabetes research group at SVI and is the current President of The Immunology of Diabetes Society (IDS) and a Council Member of the International Pancreas and Islet Transplant Association (IPITA). His major research interests include autoimmunity and islet transplants.